InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
May 15, 2023 at 11:46 am EDT
InMed Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was USD 1.03 million compared to USD 0.309585 million a year ago. Net loss was USD 2 million compared to USD 3.48 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 6.14 a year ago.
For the nine months, sales was USD 1.82 million compared to USD 0.574677 million a year ago. Net loss was USD 7.61 million compared to USD 10.73 million a year ago. Basic loss per share from continuing operations was USD 3.53 compared to USD 20.13 a year ago.